Showing results (161-170 of 407) with videos related to

Sort By:
Pageof 41
The Journal of Bone and Joint Surgery. American Volume|August 3, 2006
Surgical site infection in the elderly following orthopaedic surgery. Risk factors and outcomesJeanne Lee, Robert Singletary, Kenneth Schmader, et al.
Infection Control and Hospital Epidemiology|October 13, 2007
Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureusDeverick J Anderson, Daniel J Sexton, Zeina A Kanafani, et al.
Infectious Disease Clinics of North America|May 22, 2016
Agents of Last Resort: Polymyxin ResistanceKeith S Kaye, Jason M Pogue, Thien B Tran, et al.
Future Microbiology|March 1, 2024
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumanniiSarah M McLeod, John P O'Donnell, Navaneeth Narayanan, et al.
Pharmacotherapy|March 7, 2012
Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohortRavina Kullar, Susan L Davis, Thomas N Taylor, et al.
Emerging Infectious Diseases|April 14, 2004
Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogensMitchell J Schwaber, Sara E Cosgrove, Howard S Gold, et al.
Infection Control and Hospital Epidemiology|January 21, 2014
Readmissions after diagnosis of surgical site infection following knee and hip arthroplastyKyle G Miletic, Thomas N Taylor, Emily T Martin, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 29, 2006
Risk factors for 1-year mortality after postoperative mediastinitisRavi Karra, Lisa McDermott, Sarah Connelly, et al.
Infection Control and Hospital Epidemiology|July 10, 2004
Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and costSarah A McGarry, John J Engemann, Kenneth Schmader, et al.
Infection Control and Hospital Epidemiology|January 4, 2008
Measuring acceptable treatment failure rates for community-acquired pneumonia: potential for reducing duration of treatment and antimicrobial resistanceKeith S Kaye, Anthony D Harris, Jay R McDonald, et al.
Pageof 41